• 221 Citations
  • 7 h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2007 Ph.D., National Taiwan University Pathology 
  • 1998 MS, National Taiwan University  Pathology  
  • 1996 BS.. China Medical University   Medical Technology   

Experience

  • 2015- Assistant Professor, Ph.D. Program in Medical Biotechnology, Taipei Medical University
  • 2013- School of Medical Laboratory Science and Biotechnology Assistant Professor, Taipei Medical University
  • 2009 Seattle Childrens Research Institute fellow Ph.D
  • 2007 Department of medical Laboratory Science and Biotechnology fellow Ph.D.

Awards

  • 2011 53rd ASH abstract achievement awards- American Society of Hematology
  • 2013 55rd ASH abstract achievement awards- American Society of Hematology
  • 2013-2015 NSC University outstanding investigator recruitment award
  • 2016 Excellent research paper award-Teachers and students joint academic research symposium (TMU)
  • 2020 AAI Early Career Faculty Travel Grant - American Association of Immunologists (AAI)

Research Interests

  • Immunotherapy
  • Oncology

Fingerprint Dive into the research topics where Chao-Lien Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Targeting Ovarian Cancers with Chimeric Antigens Receptor (Cars) T-Cells Mediated Immunotherapy(1/3)

Liu, C.

8/1/197/31/20

Project: A - Government Institutionb - Ministry of Science and Technology

Engineering Chimeric Antigen Receptor T-Cells against Immune Checkpoint Inhibitor Pd1 and Pd-L1 for Treating Pancreatic Cancer(3/3)

Liu, C.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

建構抗免疫監測點抑制因子PD1 與PDL1的嵌合抗原受體T 細胞來治療胰臟癌(2/3)

Liu, C.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

抗免疫監測點抑制因子PD1 與PDL1的嵌合抗原受體修飾性γδ-T細胞用於治療卵巢癌療效之探討

Liu, C.

7/1/172/28/18

Project: A - Government Institutionb - Ministry of Science and Technology

Engineering Chimeric Antigen Receptor T-Cells against Immune Checkpoint Inhibitor Pd1 and Pd-L1 for Treating Pancreatic Cancer

Liu, C.

8/1/167/31/17

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • 221 Citations
  • 7 h-Index
  • 16 Article
Open Access
  • 1 Citation (Scopus)

    Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer

    Yang, C. Y., Fan, M. H., Miao, C. H., Liao, Y. J., Yuan, R. H. & Liu, C. L., Jun 26 2020, In : Molecular Therapy - Oncolytics. 17, p. 571-585 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Ex vivo expanded human Vγ9vδ2 T-cells can suppress epithelial ovarian cancer cell growth

    Mao, T. L., Miao, C. H., Liao, Y. J., Chen, Y. J., Yeh, C. Y. & Liu, C. L., Mar 1 2019, In : International Journal of Molecular Sciences. 20, 5, 1139.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)

    HMGCS2 mediates ketone production and regulates the proliferation and metastasis of hepatocellular carcinoma

    Wang, Y. H., Liu, C. L., Chiu, W. C., Twu, Y. C. & Liao, Y. J., Dec 2019, In : Cancers. 11, 12, 1876.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)

    SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma

    Liu, C. L., Pan, H. W., Torng, P. L., Fan, M. H. & Mao, T. L., Jan 1 2019, In : Oncology Reports. 42, 6, p. 2706-2715 10 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)